Crinetics Pharmaceuticals Inc

CRNX

Company Profile

  • Business description

    Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.

  • Contact

    6055 Lusk Boulevard
    San DiegoCA92121
    USA

    T: +1 858 450-6464

    E: [email protected]

    https://www.crinetics.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    437

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,743.6030.00-0.34%
CAC 407,691.55134.241.78%
DAX 4024,033.22383.921.62%
Dow JONES (US)43,819.27432.431.00%
FTSE 1008,798.9163.310.72%
HKSE24,284.1541.25-0.17%
NASDAQ20,273.46105.550.52%
Nikkei 22540,150.79566.211.43%
NZX 50 Index12,583.59103.540.83%
S&P 5006,173.0732.050.52%
S&P/ASX 2008,514.2036.60-0.43%
SSE Composite Index3,424.2324.23-0.70%

Market Movers